Table 5.

Twelve-month stroke outcomes and median IL-10 levels between males and females

	Composite positive, median (IQR)	Composite negative, median (IQR)
Males	NS	NS
Females	6.795 (3.6–9.99)*	9.41 (7.51–14.83)*

*p <0.05

Median IL-10 levels between male patients with composite positive and composite negative 12-month outcomes did not differ. Median IL-10 levels were higher in female patients with composite negative 12-month outcomes when compared to female patients with composite positive 12-month outcomes